Glaxo Smith Kline Menveo Meningitis Vaccine

Manufacturer #	46028020801
Brand	Menveo
Manufacturer	Glaxo Smith Kline
Application	Meningitis Vaccine
Container Type	Single Dose Vial
Dosage Form	Injection
Generic Drug Code	28272
Generic Drug Name	Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free
NDC Number	46028-0208-01
Storage Requirements	Requires Refrigeration
Strength	10 mcg - 5 mcg / 0.5 mL
Type	Intramuscular
UNSPSC Code	51201610
User	Adolescents / Adults
Volume	0.5 mL

Menveo is licensed for use in 11 to 55 year olds to help protect against potentially deadly meningitis and sepsis caused by four common vaccine-preventable serogroups
MENVEO is supplied as a vial containing MenA lyophilized conjugate component and a vial containing MenCYW-135 liquid conjugate component (1 dose after reconstitution)
There are five doses (10 vials) per package
The container closures (synthetic rubber stoppers) do not contain latex
Store refrigerated at 2 - 8 degrees celsius (36 - 46 degrees fahrenheit)
The reconstituted vaccine should be used immediately, but may be held at or below 77 degrees F (25 degrees C) for up to 8 hours

5 Each / Box

Part Number(s):